FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
FGF-2 is involved in cell survival, proliferation, apoptosis, and angiogenesis in a wide variety of cells. FRGRs, PI3K and MAP kinases are well known mediators of FGF signaling. Despite its known roles during many developmental processes, including osteogenesis, there are few known targets of FGF-2. In the present study, we identified Bcl2-A1 and Bcl-xL as two prominent targets involved in promoting cell survival. Pretreatment of ATDC5 cells with FGF-2 increased cell survival, while siRNAs specific for Bcl2-A1 and Bcl-xL compromised the anti-apoptotic effect of FGF-2, sensitized the cells to apoptosis triggered by TNF-α. Chemical inhibition of FGFR, NFkB, and PI3K activity by PD173074, pyrrolidine dithiocarbamate, and LY294002 respectively abrogated the FGF-2-mediated induction of Bcl2-A1 and Bcl-xL expression. Taken together, our data demonstrate that a subset of Bcl2 family proteins are the targets of FGF-2 signaling that promotes the survival of ATDC5cells. [BMB reports 2012; 45(5): 287-292]
Abstract
FGF-2 is involved in cell survival, proliferation, apoptosis, and angiogenesis in a wide variety of cells. FRGRs, PI3K and MAP kinases are well known mediators of FGF signaling. Despite its known roles during many developmental processes, including osteogenesis, there are few known targets of FGF-2. In the present study, we identified Bcl2-A1 and Bcl-xL as two prominent targets involved in promoting cell survival. Pretreatment of ATDC5 cells with FGF-2 increased cell survival, while siRNAs specific for Bcl2-A1 and Bcl-xL compromised the anti-apoptotic effect of FGF-2, sensitized the cells to apoptosis triggered by TNF-α. Chemical inhibition of FGFR, NFkB, and PI3K activity by PD173074, pyrrolidine dithiocarbamate, and LY294002 respectively abrogated the FGF-2-mediated induction of Bcl2-A1 and Bcl-xL expression. Taken together, our data demonstrate that a subset of Bcl2 family proteins are the targets of FGF-2 signaling that promotes the survival of ATDC5cells. [BMB reports 2012; 45(5): 287-292]
참고문헌 (25)
- Glaser, R. L., "The paternal-age effect in Apert syndrome is due, in part, to the increased frequency of mutation in sperm", Am. J. Hum. Genet., 73, pp.939~947 (2003)
- Goriely, A., "Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line", Science, 301, pp.643~ (2003)
- Feldman, B., "Requirement of FGF-4 for postimplantation mouse development", Science, 267, pp.246~249 (1995)
- Colvin, J. S., "Lung hypoplasia and neonatal death in Fgf9-nullmice identify this gene as an essential regulator of lungmesenchyme", Development, 128, pp.2095~ (2001)
- McIntosh, I., "The pleiotropic effects of fibroblast growth factor receptors in mammalian development", Cell Struct. Funct., 25, pp.85~96 (2000)
- Pardo, O. E., "Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac", DIABLO and apoptosis in small cell lung cancer cells, 2003, pp.23, 7600~7610
- Chia, S. L., "Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis", Arthritis Rheum., 60, pp.2019~2027 (2009)
- Makino, T., "Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1", 2 and JNK pathways, 2010, pp.62, 717~723
- Sahni, M., "FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway", Genes Dev., 13, pp.1361~1366 (1999)
- Krejci, P., "STAT1 and STAT3 do not participate in FGFmediated growth arrest in chondrocytes", J. Cell Sci., 121, pp.272~281 (2008)
- Youle, R. J., "The BCL-2 protein family: opposing activities that mediate cell death", Nat. Rev. Mol. Cell Biol., 9, pp.47~59 (2008)
- Lin, E. Y., "Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2", J. Immunol., 151, pp.1979~1988 (1993)
- Karsan, A., "Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1", J. Biol. Chem., 271, pp.27201~27204 (1996)
- Cross, A., "The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1", Blood, 111, pp.878~884 (2008)
- Tare, B. S., "ATDC5: an ideal cell line for development of tissue engineering strategies aimed at cartilage generation", Eur. Cell. Mater., 10(Suppl 2), pp.22~ (2005)
- Young-Sam Im, "Enhanced Cytotoxicity of 5-FU by bFGF through Up-Regulation of Uridine Phosphorylase 1", Molecules and Cells, 28(2), pp.119~124 (2009), 한국분자세포생물학회
- Reers, M., "J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential", Biochemistry, 7, pp.4480~4486 (1991)
- Shirane, M., "Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis", Nat. Cell Biol., 5, pp.28~37 (2003)
- Choi, B. H., "FKBP38 protects Bcl-2 from caspase-dependent degradation", Journal of Biological Chemistry, 285(13), pp.9770~9779 (2010), American Society for Biochemistry and Molecular Biology Inc.
- Fiebig, A. A., "Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line", BMC Cancer, 6, pp.213~ (2006)
- Vogler, M., "The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein", Biochem. Biophys. Res. Commun., 408, pp.344~349 (2011)
- Lee, H. H., "Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NFkappaB activation and intercellular adhesion molecule-1 up-regulation", Proc. Natl. Acad. Sci. U.S.A., 96, pp.1421~1426 (1999)
- Duriez, P. J., "A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor", J. Biol. Chem., 275, pp.18099~18107 (2000)
- Wang, C. Y., "NF-kappaB induces expression of the Bcl-2 homologue A1", Bfl-1 to preferentially suppress chemotherapy- induced apoptosis, 1999, pp.19, 5923~5929
- Rastegar, F., "Lysophosphatidic acid acyltransferase β (LPAAT β) promotes the tumor growth of human osteosarcoma", PLoS One, 5, pp.e14182~ (2010)